Predictors of relapses in patients with chronic inflammatory demyelinating polyneuropathy receiving subcutaneous immunoglobulin therapy – a post-hoc analysis

Journal of Neuromuscular Diseases · Published 2026-04-29 · DOI 10.1177/22143602261442297

Authors being retrieved — see the publisher record. https://doi.org/10.1177/22143602261442297

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year: 2026

Related articles

Burden of illness of Duchenne muscular dystrophy in Belgium: A retrospective, descriptive, cross-sectional study · Journal of Neuromuscular Diseases · 2026 · Same journal
Minute-by minute gait variations during the 6-Minute walk test in subjects with myotonic dystrophy type 1 · Journal of Neuromuscular Diseases · 2026 · Same journal
Congenital myasthenic syndrome due to novel GFPT1 variant presenting with head drop and visual impairment: A case report · Journal of Neuromuscular Diseases · 2026 · Same journal
Not only cross-sectional area: Echogenicity matters in nerve ultrasound studies of patients with motor multifocal neuropathy · Journal of Neuromuscular Diseases · 2026 · Same journal
Orofacial dysfunction in persons with congenital or childhood-onset neuromuscular disorders · Journal of Neuromuscular Diseases · 2026 · Same journal
Developing endpoints for the cardiac burden in myotonic dystrophy type 1: A workshop report · Journal of Neuromuscular Diseases · 2026 · Same journal
Expanding repeats, expanding impact: Somatic instability in myotonic dystrophy type 1 · Journal of Neuromuscular Diseases · 2026 · Same journal
Effects of intermittent corticosteroids on scoliosis, bone density, and vertebral fractures in duchenne muscular dystrophy · Journal of Neuromuscular Diseases · 2026 · Same journal
A qualitative study of the discrepancy between patient expectations and assessment practices in 5q-adult spinal muscular atrophy in France · Journal of Neuromuscular Diseases · 2026 · Same journal
IMU-based workspace area as a promising complementary tool to assess upper limb function in Neuromuscular diseases: A one-year follow-up · Journal of Neuromuscular Diseases · 2026 · Same journal